Pfizer Inc. has acquired exclusive rights to commercialize an obesity therapy in China, strengthening its push into the ...
From billion-dollar licensing deals to advances in cancer therapies and artificial intelligence, Chinese biotech firms are ...
Agreement worth up to $495 million is part of a growing number of Chinese deals with global pharma giants as the country ...
Chinese pharmaceutical companies that as a group chalked up record outbound licensing agreements with international industry ...
The United Laboratories International Holdings Limited (TUL) and Novo Nordisk A/S NVO on Tuesday shared topline results from ...
The country is facing a coming wave of dementia for its ageing population, and is investing in research into drugs, ...
Novo Nordisk and United Laboratories report 19.7% weight loss for UBT251 in China phase 2 obesity trial after NVO drop—get ...
Makary pointed to three bottlenecks: hospital contracting; ethical reviews and approvals; and the Investigational New Drug ...
Chinese biotech licensing deals hit a record $137.7B in 2025 as Big Pharma seeks pipeline boosts ahead of major patent cliffs ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results